New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
PMDA is regarded among the most stringent regulatory bodies globally
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer
Pharmaceutical manufacturer Wanbury Limited (WL) has strengthened its position in the Brazilian market after securing regulatory approval for Sertraline Form II from Brazil’s health regulator, ANVISA
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
